Data

India's COVID Spike and Plummet. What We Have Learned.

Mon, 2021-11-01 18:58 — mike kraft

India's COVID Spike and Plummet. What Have We Learned? Experts discuss the country's second deadly wave Shannon Firth medpagetoday

The severity of India's second COVID-19 wave took the world by surprise. Cases skyrocketed, at one point accounting for roughly half of the total infections reported globally. Then, almost as quickly, the numbers plunged.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about India's COVID Spike and Plummet. What We Have Learned.
Log in or register to post comments

With COVID-19 rising among vaccinated, health experts urge booster shots--New Hampshire data

Mon, 2021-11-01 11:59 — mike kraft

With COVID-19 rising among vaccinated, health experts urge booster shots Oct. 31—Nearly a third of those hospitalized with COVID-19 in New Hampshire in recent weeks were fully vaccinated, according to the state health department. Lori Shibinette, commissioner of the Department of Health and Human Services, said last week that breakthrough cases among those vaccinated for COVID-19 are rising, as immunity from the vaccines wanes amid the spread of the aggressive ... YahooNews

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about With COVID-19 rising among vaccinated, health experts urge booster shots--New Hampshire data
Log in or register to post comments

Analysis: This is how the pandemic start winding down in the United States

Mon, 2021-11-01 11:21 — mike kraft

How does a pandemic start winding down? You are looking at it. The United States has entered a new phase of the pandemic in which people are adapting to the persistent presence of an endemic but usually nonlethal pathogen. Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Analysis: This is how the pandemic start winding down in the United States
Log in or register to post comments

A look at whether American schools opened safely.

Mon, 2021-11-01 10:35 — mike kraft

Did America’s schools open safely? We crunched the latest data on COVID and kids. Was school reopening a success? Did masks or vaccines make a big difference? Here's what the latest stats say about COVID and kids. YahooNews

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about A look at whether American schools opened safely.
Log in or register to post comments

CDC study on breakthrough COVID-19 cases indicates age is the biggest factor

Mon, 2021-11-01 10:05 — mike kraft

Who Had Covid-19 Vaccine Breakthrough Cases? Data shows the vaccines kept working through the Delta surge, though some groups were at higher risk of breakthrough infections or death. The New York Times

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about CDC study on breakthrough COVID-19 cases indicates age is the biggest factor
Log in or register to post comments

Lancet study iquantifies effectiveness of 3rd booster shots over two doses

Mon, 2021-11-01 09:52 — mike kraft

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study Our findings suggest that a third dose of the BNT162b2 mRNA vaccine is effective in protecting individuals against severe COVID-19-related outcomes, compared with receiving only two doses at least 5 months ago. The Lancet

.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Lancet study iquantifies effectiveness of 3rd booster shots over two doses
Log in or register to post comments

Moderna says FDA needs more time to review its Covid vaccine for teens

Mon, 2021-11-01 09:41 — mike kraft

Moderna says FDA needs more time to review its Covid vaccine for teens Moderna said the FDA needs more time to complete its review of its Covid-19 vaccine for 12-to-17-year-olds before granting emergency use authorization. Jessica Dickler CNBC

Moderna said the Food and Drug Administration will need more time to complete its assessment of the biotech company’s Covid-19 vaccine for children ages 12 to 17.

Country / Region Tags:

General Topic Tags: